Multi-source financing for tuberculosis treatment in China: key issues and challenges
暂无分享，去创建一个
[1] K. Alene,et al. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview , 2020, Tropical medicine and infectious disease.
[2] K. Lönnroth,et al. The Financial Burden of Tuberculosis for Patients in the Western-Pacific Region , 2019, Tropical medicine and infectious disease.
[3] H. Kim,et al. Action towards Universal Health Coverage and Social Protection for Tuberculosis Care and Prevention: Workshop on the End TB Strategy Pillar 2 in the Western Pacific Region 2017 , 2018, Tropical medicine and infectious disease.
[4] Research in health policy making in China: out-of-pocket payments in Healthy China 2030 , 2018, British Medical Journal.
[5] D. Chin,et al. The affordability for patients of a new universal MDR-TB coverage model in China. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] K. Floyd,et al. Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention , 2014, PLoS medicine.
[7] M. Raviglione,et al. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review , 2014, European Respiratory Journal.
[8] Qian Long,et al. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review , 2011, BMC public health.